An error occurred retrieving publication content to display, please try again.
Page not found (404)
Sorry - the page you requested could not be found.
Please choose a page from the navigation or try a website search above to find the information you need.
Toolkit
The potential for heterogeneity in treatment effects, in a range of model inputs, across either tumour histologies or other characteristics, is likely to be an important issue for NICE appraisals of histology-independent technologies.
1 Centre for Reviews and Dissemination, University of York, York, UK
2 Centre for Health Economics, University of York, York, UK
3 School of Health and Related Research (ScHARR) Technology Assessment Group, University of Sheffield, Sheffield, UK
* Corresponding author Email: stephen.palmer@york.ac.uk
Declared competing interests of authors: none.
Funding: {{metadata.Funding}}
{{metadata.Journal}} Volume: {{metadata.Volume}}, Issue: {{metadata.Issue}}, Published in {{metadata.PublicationDate | date:'MMMM yyyy'}}
https://doi.org/{{metadata.DOI}}
Citation:{{author}}{{ (($index < metadata.AuthorsArray.length-1) && ($index <=6)) ? ', ' : '' }}{{(metadata.AuthorsArray.length <= 6) ? '.' : '' }} {{(metadata.AuthorsArray.length > 6) ? 'et al. ' : ''}}. {{metadata.JournalShortName}} {{metadata.PublicationDate | date:'yyyy'}};{{metadata.Volume}}({{metadata.Issue}})
Report Content
The full text of this issue is available as a PDF document from the Toolkit section on this page.
The full text of this issue is available as a PDF document from the Toolkit section on this page.
Responses to this report
No responses have been published.
An error has occurred in processing the XML document